Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1.
- DOI
- 10.3390/ph16010120
- Published
- 2023 Jan 13
- Container
- Pharmaceuticals (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ph16010120,
title = {Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1.},
author = {Molla MHR and Aljahdali MO and Sumon MAA and Asseri AH and Altayb HN and Islam MS and Alsaiari AA and Opo FADM and Jahan N and Ahammad F and Mohammad F},
year = {2023},
journal = {Pharmaceuticals (Basel, Switzerland)},
doi = {10.3390/ph16010120},
url = {https://doi.org/10.3390/ph16010120}
}RIS
TY - JOUR TI - Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1. AU - Molla MHR AU - Aljahdali MO AU - Sumon MAA AU - Asseri AH AU - Altayb HN AU - Islam MS AU - Alsaiari AA AU - Opo FADM AU - Jahan N AU - Ahammad F AU - Mohammad F PY - 2023 JO - Pharmaceuticals (Basel, Switzerland) DO - 10.3390/ph16010120 UR - https://doi.org/10.3390/ph16010120 ER -
APA
MHR, M., MO, A., MAA, S., AH, A., HN, A., MS, I., AA, A., FADM, O., N, J., F, A., & F, M. (2023). Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph16010120
Source records
- pubmed · retrieved 2026-09-26T19:53:28.223Z